Lyra Therapeutics (LYRA) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

LYRA is expected to report earnings to rise 6.94% to -19 cents per share on March 05

Lyra Therapeutics LYRA Stock Earnings Reports

Q4'24

Est.

$-0.19

Q3'24

Beat

by $0.04

Q2'24

Missed

by $0.41

Q1'24

Missed

by $0.09

Q4'23

Beat

by $0.13

The last earnings report on November 12 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 1.02M shares outstanding, the current market capitalization sits at 11.78M.

View a ticker or compare two or three

Compare

LYRA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LYRA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

480 Arsenal Way

Phone

+1 617 393-4600

Employees

145

Web

https://lyratherapeutics.com